SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 158 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,403,000 | +197.9% | 148,502 | +182.7% | 0.09% | +172.7% |
| Q2 2020 | $471,000 | +375.8% | 52,527 | +405.5% | 0.03% | +371.4% |
| Q1 2019 | $99,000 | -88.4% | 10,392 | -86.1% | 0.01% | -87.0% |
| Q4 2018 | $857,000 | +62.0% | 74,673 | +168.0% | 0.05% | +45.9% |
| Q1 2018 | $529,000 | +25.1% | 27,862 | +8.0% | 0.04% | -19.6% |
| Q4 2017 | $423,000 | -41.7% | 25,790 | -68.7% | 0.05% | -76.9% |
| Q2 2017 | $726,000 | +881.1% | 82,478 | +417.0% | 0.20% | +1070.6% |
| Q3 2016 | $74,000 | -66.7% | 15,952 | -56.5% | 0.02% | -34.6% |
| Q1 2016 | $222,000 | -60.8% | 36,687 | +1.6% | 0.03% | -55.2% |
| Q1 2015 | $566,000 | -55.7% | 36,100 | -57.0% | 0.06% | -74.3% |
| Q4 2014 | $1,277,000 | – | 83,958 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,032,980 | $12,950,000 | 1.82% |
| EcoR1 Capital, LLC | 2,308,079 | $14,702,000 | 1.54% |
| Alexandria Capital, LLC | 1,005,119 | $6,403,000 | 1.05% |
| Casdin Capital, LLC | 1,455,000 | $9,268,000 | 0.98% |
| Rhenman & Partners Asset Management AB | 700,000 | $4,459,000 | 0.62% |
| Bellevue Group AG | 3,850,000 | $24,525,000 | 0.48% |
| GREAT POINT PARTNERS LLC | 633,505 | $4,035,000 | 0.42% |
| WASATCH ADVISORS LP | 5,938,434 | $37,828,000 | 0.39% |
| 361 CAPITAL LLC | 109,161 | $695,000 | 0.32% |
| Ceeto Capital Group, LLC | 50,000 | $319,000 | 0.26% |